The Scientific Rationale of Combining Inhaled Glucocorticoids and Long Acting Beta 2 Adrenoceptor Agonists
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1863-1869
Author(s):
Alan J. Knox
NK Cells and Asthma
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1871-1876
Author(s):
Magnus Korsgren
Pandemic of Atopic Diseases - A Lack of Microbial Exposure in Early Infancy?
Journal:
Current Drug Targets - Infectious Disorders
Volume:
2
Page:
193-199
Author(s):
M. Kalliomaki and E. Isolauri
Proteoglycans in Inflammation
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
1
Page:
89-102
Author(s):
M. Delehedde, F. Allain, S. J. Payne, R. Borgo, C. Vanpouille, D. G. Fernig and E. Deudon
5-Lipoxygenase in the Central Nervous System: Therapeutic Implications
Journal:
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents
Volume:
1
Page:
115-121
Author(s):
Hari Manev and Tolga Uz
IL-4 and IL-13: Their Pathological Roles in Allergic Diseases and their Potential in Developing New Therapies
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
1
Page:
263-269
Author(s):
K. Izuhara, K. Arima and S. Yasunaga
The Use of Leukotriene Modifying Drugs in Asthma and Other Respiratory Diseases
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
1
Page:
271-275
Author(s):
J. A. Corless and M. Paracha
Oxidative Stress and Gene Transcription in Asthma and Chronic Obstructive Pulmonary Disease: Antioxidant Therapeutic Targets
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
1
Page:
291-315
Author(s):
Irfan Rahman
Thiol-Dependent Cathepsins: Pathophysiological Implications and Recent Advances in Inhibitor Design
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
1639-1658
Author(s):
Dieter Bromme and Jadwiga Kaleta
Matrix Metalloproteinases in Lung Diseases
Journal:
Current Protein & Peptide Science
Volume:
3
Page:
409-421
Author(s):
Hiroyuki Ohbayashi